The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder
- PMID: 15582922
- DOI: 10.1177/0269881104047283
The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder
Abstract
Antidepressants that inhibit the reuptake of serotonin (5-HT) are particularly effective in the treatment of panic disorder. Evidence suggests that increased 5-HT availability is important for the anti-panic effect of serotonergic drugs and in maintaining the response to selective serotonin reuptake inhibitors (SSRIs). Tianeptine is an antidepressant with 5-HT reuptake enhancing properties (i.e. the opposite pharmacological profile to that of SSRIs). Therefore, no effect would be expected in panic disorder. The aim of the present study was to compare the effect of tianeptine with that of paroxetine, a selective 5-HT reuptake inhibitor with demonstrated efficacy in panic disorder, on the vulnerability to a laboratory panic challenge in panic disorder patients. Twenty panic disorder patients were treated with either tianeptine or paroxetine for a period of 6 weeks, in a randomized, double-blind, separate group design. The reaction to a 35% CO(2) panic challenge was assessed at baseline and after treatment. Improvement on several clinical scales was also monitored. Tianeptine, as well as paroxetine, showed a significant reduction in vulnerability to the 35% CO(2) panic challenge. In spite of their opposite influence on 5-HT uptake, both tianeptine and paroxetine appeared to reduce the reaction to the panic challenge. These results raise questions about the necessity of 5-HT uptake for the therapeutic efficacy of anti-panic drugs.
Similar articles
-
Clinical and neurobiological effects of tianeptine and paroxetine in major depression.J Clin Psychopharmacol. 2003 Apr;23(2):155-68. doi: 10.1097/00004714-200304000-00008. J Clin Psychopharmacol. 2003. PMID: 12640217 Clinical Trial.
-
Treatment of panic disorder: focus on paroxetine.Psychopharmacol Bull. 2003 Spring;37 Suppl 1:53-63. Psychopharmacol Bull. 2003. PMID: 14566201 Review.
-
Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.CNS Drugs. 2002;16(1):65-75. doi: 10.2165/00023210-200216010-00005. CNS Drugs. 2002. PMID: 11772119 Clinical Trial.
-
Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine.J Psychopharmacol. 2002 Mar;16(1):5-14. doi: 10.1177/026988110201600116. J Psychopharmacol. 2002. PMID: 11949771 Clinical Trial.
-
Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.Drugs. 1998 Jan;55(1):85-120. doi: 10.2165/00003495-199855010-00007. Drugs. 1998. PMID: 9463792 Review.
Cited by
-
Effect of serotonin transporter genotype on carbon dioxide-induced fear-related behavior in mice.J Psychopharmacol. 2020 Dec;34(12):1408-1417. doi: 10.1177/0269881120959611. Epub 2020 Oct 24. J Psychopharmacol. 2020. PMID: 33103571 Free PMC article.
-
Brain Mechanisms Underlying Panic Attack and Panic Disorder.Neurosci Bull. 2024 Jun;40(6):795-814. doi: 10.1007/s12264-023-01088-9. Epub 2023 Jul 21. Neurosci Bull. 2024. PMID: 37477800 Review.
-
Lifestyle Behaviours Add to the Armoury of Treatment Options for Panic Disorder: An Evidence-Based Reasoning.Int J Environ Res Public Health. 2015 Jun 18;12(6):7017-43. doi: 10.3390/ijerph120607017. Int J Environ Res Public Health. 2015. PMID: 26095868 Free PMC article.
-
Effects of tryptophan depletion and tryptophan loading on the affective response to high-dose CO2 challenge in healthy volunteers.Psychopharmacology (Berl). 2011 Jun;215(4):739-48. doi: 10.1007/s00213-011-2177-8. Epub 2011 Feb 19. Psychopharmacology (Berl). 2011. PMID: 21336580 Free PMC article. Clinical Trial.
-
CO2 exposure as translational cross-species experimental model for panic.Transl Psychiatry. 2016 Sep 6;6(9):e885. doi: 10.1038/tp.2016.162. Transl Psychiatry. 2016. PMID: 27598969 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical